Yehuda Zisapel, Founder and President
Yehuda Zisapel holds an M.Sc. degree in Electronic Engineering from the Haifa Technion (Israel), an MBA from Tel-Aviv University (Israel), and Doctor Honoris Causa from the Technion (Israel). He is the founder and director of the RAD Group, a holding that comprises 22 high-tech companies in computer communication technologies, six of which are publicly held and traded on the NASDAQ, and the chairman of Rad-Ramot Biomedical incubator. He has served as President of Neurim Pharmaceuticals since it commenced active operations in 1992.

Nava Zisapel, Founder and Chief Scientific Officer
Nava Zisapel holds a B.Sc. in Chemistry, an M. Sc. in Biochemistry, and a Ph.D. in Biochemistry from Tel-Aviv University (Israel). She is a full professor at Tel-Aviv University with a specialization in Neuro-biochemistry and the incumbent of the Michael Gluck Chair in Neuropharmacology and ALS Research, USA. Nava Zisapel has authored with her students and collaborator scientists over 160 original research publications in peer-reviewed journals.

Yossi Elihav, Chief Financial Officer
Yossi Elihav holds a B.A. in Accounting and Economics from the Tel Aviv University (Israel). He is a Certified Public Accountant and a member of the Institute of Certified Public Accountants in Israel. Since 1998 he has been the chief financial adviser for the RAD-Bynet Group. Before joining the Group he was a partner in the firm serving as independent public accountants for the companies in the Group. In both positions he managed several IPOs on the NASDAQ. He has served Neurim in a financial capacity since the founding of the company.